Invikafusp alfa
AssetAlso called invika
Activates selected T cells through T-cell receptor binding and interleukin-2 signaling.
- Stage
- Phase 2
- Modality
- Protein or enzyme
- Target
- Not known
- 11
- Indications
- 0
- Trials
- 1
- Developer
Named in the news on Oct 23, 2026. medicalxpress.com
Indications
11Tumor mutational burden-high solid tumors
Phase 2, prnewswire.com, Oct 23, 2026
Bladder cancer
Phase 2, prnewswire.com, Oct 23, 2026
Breast cancer
Phase 2, prnewswire.com, Oct 23, 2026
8 more
In the full profile
- Owner and partners1
- Competitors12
Every asset’s record: target, stage, trials and the evidence behind it.